Joost H N Schuitemaker
Overview
Explore the profile of Joost H N Schuitemaker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pronk I, Schuitemaker J, Faas M, Smink A
J Physiol
. 2025 Mar;
PMID: 40042932
Preeclampsia is a hypertensive disorder of pregnancy and is one of the most prevalent causes of maternal and fetal morbidity and mortality. The disease is thought to originate from impaired...
2.
Dai Y, Xu X, Huo X, Schuitemaker J, Faas M
J Physiol
. 2024 Aug;
PMID: 39197088
Heavy metals disrupt mitochondrial function and activate the NOD-like receptor pyrin-containing 3 (NLRP3) inflammasome. We investigated the effect of lead (Pb)/cadmium (Cd) on mitochondrial function and NLRP3 inflammasome activation in...
3.
Dai Y, Xu X, Huo X, Schuitemaker J, Faas M
Ecotoxicol Environ Saf
. 2024 Apr;
276:116287.
PMID: 38579532
Benzo(a)pyrene (BaP) can be detected in the human placenta. However, little is known about the effects of BaP exposure on different placental cells under various conditions. In this study, we...
4.
Beernink R, Schuitemaker J, Zwertbroek E, Scherjon S, Cremers T
Placenta
. 2023 Jun;
139:112-119.
PMID: 37356366
(1) OBJECTIVE: discover new candidate biomarkers for spontaneous preterm birth in early pregnancy samples. When fully clinically validated, early pregnancy biomarkers for sPTB give the possibility to intervene or monitor...
5.
Beernink R, Zwertbroek E, Schuitemaker J, Cremers T, Scherjon S
Placenta
. 2022 Sep;
128:39-48.
PMID: 36058050
Introduction: Preeclampsia (PE) is a heterogeneous syndrome during pregnancy and postpartum and it is subdivided in this study into early onset (<34 weeks), preterm onset (34-37 weeks) and PE at...
6.
Schuitemaker J, Beernink R, Cremers T, Scherjon S, van Pampus M, Faas M
Pregnancy Hypertens
. 2021 Nov;
27:6-7.
PMID: 34800777
No abstract available.
7.
Schuitemaker J, Beernink R, Cremers T, Scherjon S, van Pampus M, Faas M
Pregnancy Hypertens
. 2021 May;
25:18-24.
PMID: 34022623
The large interferon-inducible anti-angiogenic pro-inflammatory GTPase Guanylate Binding Protein-1 (GBP-1) is produced and secreted by activated endothelial cells and is highly induced by inflammatory cytokines and inhibited by angiogenic growth...
8.
Schuitemaker J, Beernink R, Franx A, Cremers T, Koster M
PLoS One
. 2020 Nov;
15(11):e0242423.
PMID: 33206702
Background: The aim of this study was to evaluate whether soluble frizzled-related protein 4 (sFRP4) concentration in the first trimester of pregnancy is individually, or in combination with Leptin, Chemerin...
9.
Schuitemaker J, Cremers T, van Pampus M, Scherjon S, Faas M
Pregnancy Hypertens
. 2018 Apr;
12:58-64.
PMID: 29674200
Objective: We aimed to assess the levels of endothelial cell specific molecule 1 (ESM-1) during pregnancy and preeclampsia. Methods: Plasma and placental samples were collected from women with a control...
10.
Hermus L, Schuitemaker J, Tio R, Breek J, Slart R, de Boef E, et al.
Clin Biochem
. 2011 Sep;
44(16):1292-8.
PMID: 21939648
Objectives: Serum biomarkers representing inflammatory activity in vulnerable carotid plaques may be used to identify high-risk patients for cerebral ischemic events. We aimed to analyze the relationship between concentrations of...